世界の希少内分泌疾患治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Rare Endocrine Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4938 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、希少内分泌疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、有機化合物）、用途別市場規模（病院薬局、オンライン薬局、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・希少内分泌疾患治療の市場動向 ・企業の競争状況、市場シェア ・希少内分泌疾患治療の種類別市場規模（生物製剤、有機化合物） ・希少内分泌疾患治療の用途別市場規模（病院薬局、オンライン薬局、ドラッグストア） ・希少内分泌疾患治療の北米市場規模2016-2027（アメリカ、カナダ） ・希少内分泌疾患治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・希少内分泌疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・希少内分泌疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・希少内分泌疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Ipsen、Pfizer、Teva、EMD Serono、Novo Nordisk、Eli Lilly、Takeda、Amgen、Corcept Therapeutics、Novelion Therapeutics） ・結論

The endocrine system is a chemical messenger system consisting of hormones, the group of glands of an organism that carry those hormones directly into the circulatory system to be carried towards distant target organs and the feedback loops of homeostasis that the hormones drive.
The rare endocrine disease treatment market is expected to grow rapidly over the forecast period owing to the increasing prevalence of rare endocrine diseases.

Market Analysis and Insights: Global Rare Endocrine Disease Treatment Market
The global Rare Endocrine Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rare Endocrine Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rare Endocrine Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rare Endocrine Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rare Endocrine Disease Treatment market.

Global Rare Endocrine Disease Treatment Scope and Market Size
Rare Endocrine Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rare Endocrine Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Biologics
Organic Compounds

Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Ipsen
Pfizer
Teva
EMD Serono
Novo Nordisk
Eli Lilly
Takeda
Amgen

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Endocrine Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biologics
1.2.3 Organic Compounds
1.3 Market by Application
1.3.1 Global Rare Endocrine Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Rare Endocrine Disease Treatment Market Perspective (2016-2027)
2.2 Rare Endocrine Disease Treatment Growth Trends by Regions
2.2.1 Rare Endocrine Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rare Endocrine Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Rare Endocrine Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Rare Endocrine Disease Treatment Industry Dynamic
2.3.1 Rare Endocrine Disease Treatment Market Trends
2.3.2 Rare Endocrine Disease Treatment Market Drivers
2.3.3 Rare Endocrine Disease Treatment Market Challenges
2.3.4 Rare Endocrine Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Rare Endocrine Disease Treatment Players by Revenue
3.1.1 Global Top Rare Endocrine Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Rare Endocrine Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Rare Endocrine Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rare Endocrine Disease Treatment Revenue
3.4 Global Rare Endocrine Disease Treatment Market Concentration Ratio
3.4.1 Global Rare Endocrine Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Endocrine Disease Treatment Revenue in 2020
3.5 Rare Endocrine Disease Treatment Key Players Head office and Area Served
3.6 Key Players Rare Endocrine Disease Treatment Product Solution and Service
3.7 Date of Enter into Rare Endocrine Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Rare Endocrine Disease Treatment Breakdown Data by Type
4.1 Global Rare Endocrine Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Rare Endocrine Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Rare Endocrine Disease Treatment Breakdown Data by Application
5.1 Global Rare Endocrine Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Rare Endocrine Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Rare Endocrine Disease Treatment Market Size (2016-2027)
6.2 North America Rare Endocrine Disease Treatment Market Size by Type
6.2.1 North America Rare Endocrine Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Rare Endocrine Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Rare Endocrine Disease Treatment Market Size by Type (2016-2027)
6.3 North America Rare Endocrine Disease Treatment Market Size by Application
6.3.1 North America Rare Endocrine Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Rare Endocrine Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Rare Endocrine Disease Treatment Market Size by Application (2016-2027)
6.4 North America Rare Endocrine Disease Treatment Market Size by Country
6.4.1 North America Rare Endocrine Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Rare Endocrine Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Rare Endocrine Disease Treatment Market Size (2016-2027)
7.2 Europe Rare Endocrine Disease Treatment Market Size by Type
7.2.1 Europe Rare Endocrine Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Rare Endocrine Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Rare Endocrine Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Rare Endocrine Disease Treatment Market Size by Application
7.3.1 Europe Rare Endocrine Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Rare Endocrine Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Rare Endocrine Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Rare Endocrine Disease Treatment Market Size by Country
7.4.1 Europe Rare Endocrine Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Rare Endocrine Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Rare Endocrine Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Rare Endocrine Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Rare Endocrine Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rare Endocrine Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rare Endocrine Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Rare Endocrine Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Rare Endocrine Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rare Endocrine Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rare Endocrine Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Rare Endocrine Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Rare Endocrine Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rare Endocrine Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Rare Endocrine Disease Treatment Market Size (2016-2027)
9.2 Latin America Rare Endocrine Disease Treatment Market Size by Type
9.2.1 Latin America Rare Endocrine Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Rare Endocrine Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Rare Endocrine Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Rare Endocrine Disease Treatment Market Size by Application
9.3.1 Latin America Rare Endocrine Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Rare Endocrine Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Rare Endocrine Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Rare Endocrine Disease Treatment Market Size by Country
9.4.1 Latin America Rare Endocrine Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Rare Endocrine Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Rare Endocrine Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Rare Endocrine Disease Treatment Introduction
11.1.4 Novartis Revenue in Rare Endocrine Disease Treatment Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Ipsen
11.2.1 Ipsen Company Details
11.2.2 Ipsen Business Overview
11.2.3 Ipsen Rare Endocrine Disease Treatment Introduction
11.2.4 Ipsen Revenue in Rare Endocrine Disease Treatment Business (2016-2021)
11.2.5 Ipsen Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Rare Endocrine Disease Treatment Introduction
11.3.4 Pfizer Revenue in Rare Endocrine Disease Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Rare Endocrine Disease Treatment Introduction
11.4.4 Teva Revenue in Rare Endocrine Disease Treatment Business (2016-2021)
11.4.5 Teva Recent Development
11.5 EMD Serono
11.5.1 EMD Serono Company Details
11.5.2 EMD Serono Business Overview
11.5.3 EMD Serono Rare Endocrine Disease Treatment Introduction
11.5.4 EMD Serono Revenue in Rare Endocrine Disease Treatment Business (2016-2021)
11.5.5 EMD Serono Recent Development
11.6 Novo Nordisk
11.6.1 Novo Nordisk Company Details
11.6.2 Novo Nordisk Business Overview
11.6.3 Novo Nordisk Rare Endocrine Disease Treatment Introduction
11.6.4 Novo Nordisk Revenue in Rare Endocrine Disease Treatment Business (2016-2021)
11.6.5 Novo Nordisk Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Rare Endocrine Disease Treatment Introduction
11.7.4 Eli Lilly Revenue in Rare Endocrine Disease Treatment Business (2016-2021)
11.7.5 Eli Lilly Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Rare Endocrine Disease Treatment Introduction
11.8.4 Takeda Revenue in Rare Endocrine Disease Treatment Business (2016-2021)
11.8.5 Takeda Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Rare Endocrine Disease Treatment Introduction
11.9.4 Amgen Revenue in Rare Endocrine Disease Treatment Business (2016-2021)
11.9.5 Amgen Recent Development
11.10 Corcept Therapeutics
11.10.1 Corcept Therapeutics Company Details
11.10.2 Corcept Therapeutics Business Overview
11.10.3 Corcept Therapeutics Rare Endocrine Disease Treatment Introduction
11.10.4 Corcept Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2016-2021)
11.10.5 Corcept Therapeutics Recent Development
11.11 Novelion Therapeutics
11.11.1 Novelion Therapeutics Company Details
11.11.2 Novelion Therapeutics Business Overview
11.11.3 Novelion Therapeutics Rare Endocrine Disease Treatment Introduction
11.11.4 Novelion Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2016-2021)
11.11.5 Novelion Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Rare Endocrine Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biologics
Table 3. Key Players of Organic Compounds
Table 4. Global Rare Endocrine Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Rare Endocrine Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Rare Endocrine Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Rare Endocrine Disease Treatment Market Share by Regions (2016-2021)
Table 8. Global Rare Endocrine Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Rare Endocrine Disease Treatment Market Share by Regions (2022-2027)
Table 10. Rare Endocrine Disease Treatment Market Trends
Table 11. Rare Endocrine Disease Treatment Market Drivers
Table 12. Rare Endocrine Disease Treatment Market Challenges
Table 13. Rare Endocrine Disease Treatment Market Restraints
Table 14. Global Rare Endocrine Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Rare Endocrine Disease Treatment Market Share by Players (2016-2021)
Table 16. Global Top Rare Endocrine Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Endocrine Disease Treatment as of 2020)
Table 17. Ranking of Global Top Rare Endocrine Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Rare Endocrine Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Rare Endocrine Disease Treatment Product Solution and Service
Table 21. Date of Enter into Rare Endocrine Disease Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Rare Endocrine Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Rare Endocrine Disease Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Rare Endocrine Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Rare Endocrine Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Rare Endocrine Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Rare Endocrine Disease Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Rare Endocrine Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Rare Endocrine Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Rare Endocrine Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Rare Endocrine Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Rare Endocrine Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Rare Endocrine Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Rare Endocrine Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Rare Endocrine Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Rare Endocrine Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Rare Endocrine Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Rare Endocrine Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Rare Endocrine Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Rare Endocrine Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Rare Endocrine Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Rare Endocrine Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Rare Endocrine Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Rare Endocrine Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Rare Endocrine Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Rare Endocrine Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Rare Endocrine Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Rare Endocrine Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Rare Endocrine Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Rare Endocrine Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Rare Endocrine Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Rare Endocrine Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Rare Endocrine Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Rare Endocrine Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Rare Endocrine Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Rare Endocrine Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Rare Endocrine Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Rare Endocrine Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Rare Endocrine Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Rare Endocrine Disease Treatment Product
Table 64. Novartis Revenue in Rare Endocrine Disease Treatment Business (2016-2021) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Ipsen Company Details
Table 67. Ipsen Business Overview
Table 68. Ipsen Rare Endocrine Disease Treatment Product
Table 69. Ipsen Revenue in Rare Endocrine Disease Treatment Business (2016-2021) & (US$ Million)
Table 70. Ipsen Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Rare Endocrine Disease Treatment Product
Table 74. Pfizer Revenue in Rare Endocrine Disease Treatment Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Teva Company Details
Table 77. Teva Business Overview
Table 78. Teva Rare Endocrine Disease Treatment Product
Table 79. Teva Revenue in Rare Endocrine Disease Treatment Business (2016-2021) & (US$ Million)
Table 80. Teva Recent Development
Table 81. EMD Serono Company Details
Table 82. EMD Serono Business Overview
Table 83. EMD Serono Rare Endocrine Disease Treatment Product
Table 84. EMD Serono Revenue in Rare Endocrine Disease Treatment Business (2016-2021) & (US$ Million)
Table 85. EMD Serono Recent Development
Table 86. Novo Nordisk Company Details
Table 87. Novo Nordisk Business Overview
Table 88. Novo Nordisk Rare Endocrine Disease Treatment Product
Table 89. Novo Nordisk Revenue in Rare Endocrine Disease Treatment Business (2016-2021) & (US$ Million)
Table 90. Novo Nordisk Recent Development
Table 91. Eli Lilly Company Details
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly Rare Endocrine Disease Treatment Product
Table 94. Eli Lilly Revenue in Rare Endocrine Disease Treatment Business (2016-2021) & (US$ Million)
Table 95. Eli Lilly Recent Development
Table 96. Takeda Company Details
Table 97. Takeda Business Overview
Table 98. Takeda Revenue in Rare Endocrine Disease Treatment Business (2016-2021) & (US$ Million)
Table 99. Takeda Recent Development
Table 100. Amgen Company Details
Table 101. Amgen Business Overview
Table 102. Amgen Rare Endocrine Disease Treatment Product
Table 103. Amgen Revenue in Rare Endocrine Disease Treatment Business (2016-2021) & (US$ Million)
Table 104. Amgen Recent Development
Table 105. Corcept Therapeutics Company Details
Table 106. Corcept Therapeutics Business Overview
Table 107. Corcept Therapeutics Rare Endocrine Disease Treatment Product
Table 108. Corcept Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2016-2021) & (US$ Million)
Table 109. Corcept Therapeutics Recent Development
Table 110. Novelion Therapeutics Company Details
Table 111. Novelion Therapeutics Business Overview
Table 112. Novelion Therapeutics Rare Endocrine Disease Treatment Product
Table 113. Novelion Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2016-2021) & (US$ Million)
Table 114. Novelion Therapeutics Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare Endocrine Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Biologics Features
Figure 3. Organic Compounds Features
Figure 4. Global Rare Endocrine Disease Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Online Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Rare Endocrine Disease Treatment Report Years Considered
Figure 9. Global Rare Endocrine Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Rare Endocrine Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Rare Endocrine Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Rare Endocrine Disease Treatment Market Share by Regions (2022-2027)
Figure 13. Global Rare Endocrine Disease Treatment Market Share by Players in 2020
Figure 14. Global Top Rare Endocrine Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Endocrine Disease Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Rare Endocrine Disease Treatment Revenue in 2020
Figure 16. Global Rare Endocrine Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Rare Endocrine Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Rare Endocrine Disease Treatment Market Share by Type (2016-2027)
Figure 20. North America Rare Endocrine Disease Treatment Market Share by Application (2016-2027)
Figure 21. North America Rare Endocrine Disease Treatment Market Share by Country (2016-2027)
Figure 22. United States Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Rare Endocrine Disease Treatment Market Share by Type (2016-2027)
Figure 26. Europe Rare Endocrine Disease Treatment Market Share by Application (2016-2027)
Figure 27. Europe Rare Endocrine Disease Treatment Market Share by Country (2016-2027)
Figure 28. Germany Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Rare Endocrine Disease Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Rare Endocrine Disease Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Rare Endocrine Disease Treatment Market Share by Region (2016-2027)
Figure 38. China Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Rare Endocrine Disease Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Rare Endocrine Disease Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Rare Endocrine Disease Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Rare Endocrine Disease Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Rare Endocrine Disease Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Rare Endocrine Disease Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Rare Endocrine Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novartis Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2016-2021)
Figure 58. Ipsen Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2016-2021)
Figure 60. Teva Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2016-2021)
Figure 61. EMD Serono Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2016-2021)
Figure 62. Novo Nordisk Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2016-2021)
Figure 64. Takeda Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2016-2021)
Figure 65. Amgen Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2016-2021)
Figure 66. Corcept Therapeutics Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2016-2021)
Figure 67. Novelion Therapeutics Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---